Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation

Minnie M. Sarwal*, Alkesh Jani, Stella Chang, Phil Huie, Zhuo Wang, Oscar Salvatierra, Carol Clayberger, Richard Sibley, Alan M. Krensky, Martha Pavlakis

*Corresponding author for this work

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

Differentiating etiologies of transplant dysfunction without biopsy and optimizing therapy for acute rejection by predicting steroid resistance will reduce patient morbidity. Granulysin is a cytolytic molecule released by CTL and NK cells and coexpressed with effectors of acute allograft rejection, like perforin and granzymes. Granulysin mRNA and protein expression were studied in peripheral blood lymphocytes (PBL; n = 61 total, n = 10 with intercurrent infections) and biopsy tissue from adult and children renal transplant recipients (n = 97) by competitive quantitative-reverse transcriptase-PCR (QC-RT-PCR) and immunohistochemistry. Differences in cell phenotypes were studied in steroid sensitive and resistant acute rejection biopsies. Granulysin was studied in phytohemagglutinin (PHA) stimulated cell lines (donor PBL and CD45RO+ T cells) by FACS, Western blotting, and RT-PCR after pretreating with cyclosporine A (CSA), azathioprine, mycophenolic acid, and steroids. Granulysin mRNA was significantly increased in patient PBL and transplant biopsies during acute rejection (p < 0.0001) and infection (p < 0.001). Rejecting biopsies alone (n = 53) had mononuclear cell granulysin staining. Steroid resistant biopsies (n = 25) had denser granulysin staining (>2 cells/high power field) and CD45RO+ lymphocytes, when compared with steroid sensitive (n = 28) rejecting tissue. Granulysin levels were unchanged after azathioprine and mycophenolic acid treatment, decreased after treating activated PBL with steroids and cyclosporine A (CSA), and paradoxically, increased (p < 0.05) after treating CD45RO+ CTL with CSA. Elevated PBL granulysin is a peripheral marker for acute rejection and infection and dense granulysin staining a tissue marker for steroid resistance. Memory CTL abound in steroid resistant grafts and may have a markedly different response to CSA immunotherapy, suggesting a possible mechanism for steroid resistance.

Original languageEnglish (US)
Pages (from-to)21-31
Number of pages11
JournalHuman Immunology
Volume62
Issue number1
DOIs
StatePublished - Feb 28 2001

Keywords

  • Acute rejection
  • Granulysin
  • Kidney transplant
  • Noninvasive
  • Steroid resistance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation'. Together they form a unique fingerprint.

  • Cite this

    Sarwal, M. M., Jani, A., Chang, S., Huie, P., Wang, Z., Salvatierra, O., Clayberger, C., Sibley, R., Krensky, A. M., & Pavlakis, M. (2001). Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Human Immunology, 62(1), 21-31. https://doi.org/10.1016/S0198-8859(00)00228-7